Eric K. Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on X:
“BAY88 has a name – Sevabertinib
Dr. Xiuning Le excellently reviews updates for the drug. Although small numbers, for treatment-naive patients, ORR ~60%.”
More posts featuring Eric K. Singhi.
